Page last updated: 2024-11-07

aldosterone and Osteoporosis, Postmenopausal

aldosterone has been researched along with Osteoporosis, Postmenopausal in 2 studies

Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shu, X1
Mei, M1
Ma, L1
Wang, Z1
Yang, S1
Hu, J1
Song, Y1
He, W1
Luo, T1
Cheng, Q1
Wang, Y1
Zhen, Q1
Li, Q1
Morgante, G1
Delia, A1
Musacchio, MC1
Severi, FM1
Petraglia, F1
De Leo, V1

Trials

1 trial available for aldosterone and Osteoporosis, Postmenopausal

ArticleYear
Effects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal women.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2006, Volume: 22, Issue:7

    Topics: Aldosterone; Antihypertensive Agents; Blood Pressure; Bone Density; Female; Humans; Middle Aged; Ost

2006

Other Studies

1 other study available for aldosterone and Osteoporosis, Postmenopausal

ArticleYear
Postmenopausal osteoporosis is associated with elevated aldosterone/renin ratio.
    Journal of human hypertension, 2018, Volume: 32, Issue:7

    Topics: Aldosterone; Case-Control Studies; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Renin;

2018